{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:06:08Z","timestamp":1792706768475,"version":"4.5.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.43001","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T16:04:11Z","timestamp":1641830651000},"page":"e2143001","source":"Crossref","is-referenced-by-count":28,"title":["Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial"],"prefix":"10.1001","volume":"5","author":[{"given":"Alexander R.","family":"Zheutlin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Utah, School of Medicine, Salt Lake City"},{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favel L.","family":"Mondesir","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine G.","family":"Derington","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan B.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City"},{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Utah, School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan R.","family":"Berlowitz","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Massachusetts-Lowell, Lowell"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Edmund","family":"Anstey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cushman","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis"},{"name":"Medical Service, Memphis VA Medical Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.","family":"Greene","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olugbenga","family":"Ogedegbe","sequence":"additional","affiliation":[{"name":"Center for Healthful Behavior Change, Division of Health and Behavior, Department of Population Health, New York University School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah, School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"7","key":"zoi211195r1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIR.0000000000000071","article-title":"Status of cardiovascular disease and stroke in Hispanics\/Latinos in the United States: a science advisory from the American Heart Association.","volume":"130","author":"Rodriguez","year":"2014","journal-title":"Circulation"},{"issue":"21","key":"zoi211195r2","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association.","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"zoi211195r3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018.","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"zoi211195r4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2215\/CJN.06180616","article-title":"Recognition and management of resistant hypertension.","volume":"12","author":"Braam","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"zoi211195r5","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018.","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"issue":"25","key":"zoi211195r6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011121","article-title":"Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis.","volume":"97","author":"Milman","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"zoi211195r7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.18553\/jmcp.2009.15.8.690","article-title":"Nonadherence, clinical inertia, or therapeutic inertia?","volume":"15","author":"Allen","year":"2009","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"zoi211195r8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3949\/ccjm.79a.11068","article-title":"Overcoming barriers to hypertension control in African Americans.","volume":"79","author":"Odedosu","year":"2012","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"zoi211195r9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/HYPERTENSIONAHA.112.192096","article-title":"The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.","volume":"60","author":"Daugherty","year":"2012","journal-title":"Hypertension"},{"key":"zoi211195r10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2296-15-130","article-title":"The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review.","volume":"15","author":"Lebeau","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"5","key":"zoi211195r11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/jch.2012.14.issue-5","article-title":"Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial.","volume":"14","author":"Huebschmann","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"zoi211195r12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ajh.2009.201","article-title":"Racial disparities in hypertension control, but not treatment intensification.","volume":"23","author":"Umscheid","year":"2010","journal-title":"Am J Hypertens"},{"issue":"8","key":"zoi211195r13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11606-010-1342-9","article-title":"Understanding racial disparities in treatment intensification for hypertension management.","volume":"25","author":"Manze","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"7","key":"zoi211195r14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s11606-014-2795-z","article-title":"An investigation of associations between clinicians\u2019 ethnic or racial bias and hypertension treatment, medication adherence and blood pressure control.","volume":"29","author":"Blair","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"7624","key":"zoi211195r15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"22","key":"zoi211195r16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi211195r17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"5","key":"zoi211195r19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial).","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"issue":"13","key":"zoi211195r20","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jama.2019.1954","article-title":"Marginal effects-quantifying the effect of changes in risk factors in logistic regression models.","volume":"321","author":"Norton","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi211195r21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/2013.jamainternmed.955","article-title":"Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.","volume":"173","author":"Adams","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"7","key":"zoi211195r22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/jgs.2012.60.issue-7","article-title":"Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries.","volume":"60","author":"Holmes","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi211195r23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212117","article-title":"Racial and ethnic disparities in medication adherence among privately insured patients in the United States.","volume":"14","author":"Xie","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"zoi211195r24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.110.161950","article-title":"Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey.","volume":"57","author":"Redmond","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"zoi211195r25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/HYPERTENSIONAHA.116.07720","article-title":"Trends in antihypertensive medication discontinuation and low adherence among medicare beneficiaries initiating treatment from 2007 to 2012.","volume":"68","author":"Tajeu","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"zoi211195r26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004188","article-title":"Treatment intensification for hypertension in US ambulatory medical Care.","volume":"5","author":"Mu","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"zoi211195r27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.7326\/0003-4819-148-10-200805200-00011","article-title":"It\u2019s time to overcome clinical inertia.","volume":"148","author":"Phillips","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi211195r28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","article-title":"Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.","volume":"47","author":"Okonofua","year":"2006","journal-title":"Hypertension"},{"key":"zoi211195r29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/pharmtox.2017.57.issue-1","article-title":"Changing provider behavior in the context of chronic disease management: focus on clinical inertia.","volume":"57","author":"Lavoie","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"zoi211195r30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005624","article-title":"Clinic-based strategies to reach United States Million Hearts 2022 blood pressure control goals.","volume":"12","author":"Bellows","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"zoi211195r31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11606-008-0507-2","article-title":"Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension.","volume":"23","author":"Bolen","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi211195r32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/jch.2002.4.issue-6","article-title":"Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"zoi211195r33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/jch.2017.19.issue-7","article-title":"Measure accurately, act rapidly, and partner with patients: an intuitive and practical three-part framework to guide efforts to improve hypertension control.","volume":"19","author":"Boonyasai","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"zoi211195r34","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/HYPERTENSIONAHA.118.11558","article-title":"Improving hypertension control in primary care with the measure accurately, act rapidly, and partner with patients protocol results at 6 and 12 months.","volume":"72","author":"Egan","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"zoi211195r35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7812\/TPP\/15-052","article-title":"Population care management and team-based approach to reduce racial disparities among African Americans\/Blacks with hypertension.","volume":"20","author":"Bartolome","year":"2016","journal-title":"Perm J"},{"issue":"7","key":"zoi211195r36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program.","volume":"310","author":"Jaffe","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"zoi211195r37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/jch.12803","article-title":"The Kaiser Permanente Northern California Story: improving hypertension control from 44% to 90% in 13 Years (2000 to 2013).","volume":"18","author":"Jaffe","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"zoi211195r38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11906-018-0802-1","article-title":"Therapeutic inertia and treatment intensification.","volume":"20","author":"Josiah Willock","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"zoi211195r39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7326\/M17-1805","article-title":"Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: A systematic review and meta-analysis.","volume":"168","author":"Mills","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi211195r40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11906-019-0996-x","article-title":"Cost-effectiveness and challenges of implementing intensive blood pressure goals and team-based care.","volume":"21","author":"Derington","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"zoi211195r18","unstructured":"Systolic Blood Pressure Intervention Trial (SPRINT) protocol version 4.0. October 15, 2015. Accessed December 2, 2021. https:\/\/www.sprinttrial.org\/public\/Protocol_Current.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2787766\/zheutlin_2022_oi_211195_1643380185.29679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T13:05:19Z","timestamp":1674392719000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2787766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43001","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}